Meningococcal disease is an infection caused by a type of bacteria called Neisseria meningitidis. There are two types of ...

HEALTH experts are raising awareness about Invasive Meningococcal Disease (IMD), a rare but life-threatening bacterial infection, urging the government to provi ...

TUESDAY, Feb. 18, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active immunization against invasive ...

The concomitant administration of multiple vaccines at a single clinic visit reduces the number of required visits to healthcare providers and can improve compliance with vaccine recommendations ...

When the committee reevaluates its recommendations, it should give greater weight to feasibility and implementation ...

The FDA approved GSK's Penmenvy vaccine for ages 10-25, targeting five major meningococcal serogroups: A, B, C, W, and Y. Phase 3 trials with 4,800 participants showed the vaccine has a safety ...

Penmenvy protects against meningococcal serotypes A, B, C, W and Y. CDC vaccine advisors are set to discuss recommendations for the vaccine on Feb. 26. The FDA approved GSK’s pentavalent ...

Researchers helped conduct an important new global health study that found a vaccine that protects against five strains of meningitis prevalent in sub-Saharan Africa is safe and effective for use in ...

MCC vaccination has had important consequences for meningococcal population biology, and carriage studies were essential in measuring these effects. The potential for herd immunity should be taken ...

The vaccine targets five major serogroups of Neisseria meningitidis (A, B, C, W, and Y) which commonly cause invasive meningococcal disease (IMD).1,2 Tony Wood, Chief Scientific Officer, ...

FDA Approves 5-in-1 Vaccine Against Meningococcal DiseaseThe FDA has approved Penmenvy, a new 5-in-1 shot to protect against meningococcal infections or invasive meningococcal disease (IMD ...